Anthropic's president says market incentives alone would not have produced its 100-country medical AI rollout

Anthropic supplies the models and OpenEvidence adapts them to local medicine ^[1]. Inference is the recurring cost of that split, and it rises with use. In the US, doctors ran 42 million queries through OpenEvidence in August alone, founder Daniel Nadler told Reuters ^[7], which works out at about 1.35 million a day ^[8]. Neither published account says what the new program costs or who pays for the compute ^[22].

OpenEvidence has been free to clinicians in the US and Europe for some time ^[4], and the specialized version for low- and middle-income countries is free as well ^[3]. The change is where it is offered. Anthropic president Daniela Amodei told Reuters that the technology had become capable enough for the initiative but that "market incentives by themselves would not cause it to happen" without a philanthropic push ^[10]. An officer of the company is saying the usage does not pay for itself.

Last week Anthropic built a lab for physical biology work aimed at drug development ^[17]. What it gets back for the clinical giveaway is sentiment, and it has already put that argument in front of investors ^[18].

Checking the distribution case is harder. More than a million queries a day inside clinical workflow is a position of some value, and PYMNTS Intelligence has found that AI adoption in healthcare is not as extensive as in sectors such as financial services ^[20], so getting in early on how doctors look things up may be worth money later.

The first thing that can go wrong is clinical. Reuters reported the criticism that systems trained primarily on data from wealthier countries may not align with "local practice conditions" ^[14]. "One hundred percent of what we are developing for these areas is designed to be context adaptive," Nadler said ^[13], and the company worked with healthcare organizations in Rwanda and Botswana earlier this year to adapt its tools ^[15]. Delivery is a separate constraint: Nadler said most doctors still have smartphones even where clinics have inconsistent power ^[16]. Ahmed Bendary, a cardiologist at Benha University in Egypt, told Reuters that the expansion is especially important for doctors in places where access to medical research is limited ^[19].

I think the philanthropic reading is right, because Anthropic's president gave it on the record and dated it to a push that market pricing would not have funded ^[10]. The counter-thesis is that free access across about 100 countries is a cheap way into clinical care, and that a platform absorbing 42 million US queries a month will charge somebody for them eventually ^[3][7]. Two developments would settle it against the first reading: a paid tier in any of the new markets, or a renewal of the program that needs no philanthropic money.